Sarclisa Approved in China as First Anti-CD38 Treatment for Newly Diagnosed Multiple Myeloma Read more
Kazia Therapeutics Launches Groundbreaking Trial of Paxalisib and Immunotherapy for Advanced Breast Cancer Read more
FDA Grants Priority Review to Merck’s WELIREG for Advanced Pheochromocytoma and Paraganglioma Read more
Pfizer’s BRAFTOVI Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer Read more
AbbVie and Neomorph Partner to Develop Molecular Glue Degraders for Oncology and Immunology Read more